Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pulmonary-delivered insulin advances through clinical trials

Nov. 1, 1996

Lilly reports long-acting, soluble insulin analogues

Nov. 1, 1996

Hypoglycemic agents disclosed by Yamanouchi

Nov. 1, 1996

Sheffield Medical Technologies and Alpha Therapeutic enter into option agreement

Nov. 1, 1996

Oncogene awarded drug discovery grant

Nov. 1, 1996

Lilly and Neurocrine collaborate in the areas of obesity and Alzheimer's disease

Nov. 1, 1996

Antiobesity proteins described by Lilly

Nov. 1, 1996

CRADA opportunity for the treatment of atherosclerosis and LCAT deficiency

Nov. 1, 1996

Mitsubishi to copromote OrthoLogic 1000 in Japan

Nov. 1, 1996

FCP-3P1 in Canadian clinical trials

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...